Weekly Reports | Oct 07 2022
Our top ten news from 29 September 2022 to 06 October 2022 (ranked according to popularity).
1 – Australian House Prices Could Fall Twenty Percent
Thursday 29 September 2022
The US Federal Reserve's policy aggression will force the RBA into further rate hikes that will potentially lead to a bigger house price fall than previously feared
2 – The Short Report – 29 Sep 2022
Thursday 29 September 2022
FNArena's weekly update on short positions in the Australian share market
3 – In Brief: Inflation, Property Sentiment, Bank Buybacks, Gaming Regulation
Friday 30 September 2022
Weekly broker wrap: impacts of further fiscal support, low property sentiment, declining bank equity, gaming regulatory concerns
4 – Weekly Ratings, Targets, Forecast Changes – 30-09-22
Monday 03 October 2022
Weekly update on stockbroker recommendation, target price, and earnings forecast changes
5 – ESG Focus: Biodiversity Ready To Roll
Friday 30 September 2022
Biodiversity has been the long-mooted laggard on the ESG front, but the new ESG investment category has come of age
6 – PayTo: Blockchain Changing The World Of Finance
Monday 03 October 2022
PayTo is ready to revolutionise the direct debit industry with benefits for customers, businesses and the banks
7 – Australian Listed Real Estate Tables – 03-10-2022
Monday 03 October 2022
FNArena provides a weekly update of Australian listed real estate trusts (REIT) and property developers, current pricing yield and valuation data
8 – Uranium Week: Contango
Tuesday 04 October 2022
As financial market turmoil weighs on the spot uranium market while term market demand remains elevated, the uranium curve has moved into contango
9 – Rudi's View: Good News, How To Use PE Ratios & Conviction Calls
Thursday 29 September 2022
In this week's Weekly Insights:-Good News-PEs – The Tool That Both Enlightens And Confuses-Conviction Calls-Research To Download-FNArena Talks (3x)By Rudi Filapek-Vandyck, EditorGood NewsA brutal September has pushed the market indicator that used to be known as Citi's Pa
10 – Brokers Review Prospects For CSL
Friday 30 September 2022
Brokers remain generally upbeat on CSL and focus upon the earnings contribution from the Vifor Pharma acquisition